Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.

Literature DB >> 31509758

Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.

Lawrence A Donehower, Thierry Soussi, Anil Korkut, Yuexin Liu, Andre Schultz, Maria Cardenas, Xubin Li, Ozgun Babur, Teng-Kuei Hsu, Olivier Lichtarge, John N Weinstein, Rehan Akbani, David A Wheeler.

Abstract

Entities: Gene

Year: 2019 PMID： 31509758 DOI： 10.1016/j.celrep.2019.08.061

Source DB: PubMed Journal: Cell Rep Impact factor: 9.423

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

Review 1. AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

Authors: Bowen Yan; David Claxton; Suming Huang; Yi Qiu
Journal: Exp Hematol Date: 2020-06-20 Impact factor: 3.084

2. Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors: Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal: NAR Cancer Date: 2022-03-03

3. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

Authors: Apostolos Klinakis; Theodoros Rampias
Journal: EBioMedicine Date: 2020-07-30 Impact factor: 8.143

4. Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.

Authors: Talayeh S Ghezelayagh; Kathryn P Pennington; Barbara M Norquist; Nithisha Khasnavis; Marc R Radke; Mark R Kilgore; Rochelle L Garcia; Ming Lee; Ronit Katz; Kimberly K Leslie; Rosa Ana Risques; Elizabeth M Swisher
Journal: Gynecol Oncol Date: 2020-12-26 Impact factor: 5.482

10. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.

Authors: Cecilia Gola; Diana Giannuzzi; Andrea Rinaldi; Selina Iussich; Paola Modesto; Emanuela Morello; Paolo Buracco; Luca Aresu; Raffaella De Maria
Journal: Front Vet Sci Date: 2021-05-17

Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.

Review 1. AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

2. Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

3. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

4. Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.

5. Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Review 6. Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma.

7. Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.

8. A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement.

9. Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity.

10. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.